Target intelligence / Profile preview

RNA, U6 small nuclear 129, pseudogene (RNU6-129P)

Target
RNU6-129P
Molecular classification
Other (Pseudogene, non-coding RNA pseudogene)
01

Overview

RNA, U6 small nuclear 129, pseudogene (RNU6-129P) is classified as a pseudogene related to the family of U6 small nuclear RNAs, which are core non-coding RNA components of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes. As a pseudogene, RNU6-129P is considered non-functional in terms of encoding an active snRNA or protein product. While active U6 snRNA genes play an essential role in catalyzing splicing reactions, pseudogenes like RNU6-129P typically arise from duplication or retrotransposition events and generally lack the regulatory elements or sequence integrity to produce functional transcripts[1][5][4]. Some pseudogenes in the genome can generate regulatory RNAs with possible roles in gene regulation (e.g., as antisense RNAs or competing endogenous RNAs), but there is no specific evidence that RNU6-129P is functional or implicated in disease, nor is it a therapeutic target[4][5][1]. This locus is important primarily as a genomic marker and not as a direct functional molecule.

Other names
RNU6-129P
02

Biological functions

Possible gene regulation via RNA, no direct protein-coding or canonical molecular function
03

Disease associations

Other (Pseudogenes in general can have disease associations, but specific evidence for RNU6-129P is lacking)

Beyond the preview

Go deeper on RNA, U6 small nuclear 129, pseudogene (RNU6-129P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 129, pseudogene (RNU6-129P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call